Immunomodulatory effects of silymarin after subacute exposure to mice: A tiered approach immunotoxicity screening |
Karimi, Gholamreza
(Pharmaceutical Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences)
Hassanzadeh-Josan, Samed (Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences) Memar, Bahram (Cancer Research Center, Faculty of Medicine, Mashhad University of Medical Sciences) Esmaeili, Seyed-Alireza (Immunology Research Center, BuAli Research Institute, Faculty of Medicine, Mashhad University of Medical Sciences) Riahi-Zanjani, Bamdad (Medical Toxicology Research Center, Mashhad University of Medical Sciences) |
1 | Farsam V, Hassan ZM, Zavaran-Hosseini A, Noori S, Mahdavi M, Ranjbar M. Antitumor and immunomodu- latory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ T reg cells in vivo. Int Immunop-harmacol. 2011;11(11):1802-8. DOI |
2 | Riahi-Zanjani B, Balali-Mood M, Mohammadi E, Badie-Bostan H, Memar B, Karimi G. Safranal as a safe compound to mice immune system. Avicenna J Phytomed. 2015;5(5):441. |
3 | Shirani K, Hassani FV, Razavi-Azarkhiavi K, Heidari S, Zanjani BR, Karimi G. Phytotrapy of cyclophospha-mide-induced immunosuppression. Environ Toxicol Pharmacol. 2015;39(3):1262-75. DOI |
4 | Noori S, Taghikhani M, Hassan ZM, Allameha A, Mostafaei A. Tehranolide molecule modulates the immune response, reduce regulatory T cell and inhibits tumor growth in vivo. Molecul Immunol. 2010;47(7):1579-84. DOI |
5 | Rahnama M, Mahmoudi M, Zamani Taghizadeh Rabe S, Balali-Mood M, Karimi G, Tabasi N, et al. Evaluation of anti-cancer and immunomodulatory effects of carnosol in a Balb/c WEHI-164 fibrosarcoma model. J Immunotoxicol. 2015;12(3):231-8. DOI |
6 | Hasani-Ranjbar S, Larijani B, Abdollahi M. A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases. Infamma Allergy Drug Targets. 2009;8(1):2-10. DOI |
7 | Elyasi S, Shojaee FSR, Allahyari A, Karimi G. Topical Silymarin Administration for Prevention of Capecit-abine-Induced Hand-Foot Syndrome: A Randomized, Double‐Blinded, Placebo‐Controlled Clinical Trial. Phytother Res. 2017;31(9):1323-9. DOI |
8 | Agarwal R, Agarwal C, Ichikawa H, Singh RP, Aggarwal BB. Anticancer potential of silymarin: from bench to bed side. Anticancer Res. 2006;26(6B):4457-98. |
9 | Elyasi S, Hosseini S, Niazi Moghadam MR, Aledavood SA, Karimi G. Effect of Oral Silymarin Administration on Prevention of Radiotherapy Induced Mucositis: A Randomized, Double‐Blinded, Placebo‐Controlled Clinical Trial. Phytother Res. 2016;30(11):1879-85. DOI |
10 | Karimi G, Vahabzadeh M, Lari P, Rashedinia M, Moshiri M. "Silymarin", a promising pharmacological agent for treatment of diseases. Iran J Basic Med Sci. 2011(4);14:308. |
11 | Vargas-Mendoza N, Madrigal-Santillan E, Morales-Gonzalez A, Esquivel-Soto J, Esquivel- Chirino C, y Gonzalez-Rubio MG-L, et al. Hepatoprotective effect of silymarin. World J Hepatol. 2014;6(3):144. DOI |
12 | Razavi BM, Karimi G. Protective effect of silymarin against chemical-induced cardiotoxicity. Iran J Basic Med Sci. 2016;19(9):916. |
13 | Darvishi Khezri H, Salehifar E, Kosaryan M, Aliasgh-arian A, Jalali H, Hadian Amree A. Potential effects of silymarin and its flavonolignan components in patients with ‐-Talassemia major: a comprehensive review in 2015. Adv Pharmacol Sci. 2016;2016. |
14 | Gharagozloo M, Velardi E, Bruscoli S, Agostini M, Di Sante M, Donato V, et al. Silymarin suppress CD4+ T cell activation and proliferation: Effects on NF- activity and IL-2 production. Pharmacol Res. 2010;61(5):405-9. DOI |
15 | Choi YH, Jin GY, Guo HS, Piao HM, chang Li L, Li GZ, et al. Silibinin attenuates allergic airway inflammation in mice. Biochem Biophys Res Commun. 2012;427(3):450-5. DOI |
16 | Morishima C, Shuhart MC, Wang CC, Paschal DM, Apodaca MC, Liu Y, et al. Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection. Gastroenterol. 2010;138(2):671-81. e2. DOI |
17 | Johnson VJ, He Q, Osuchowski MF, Sharma RP. Physiological Responses of a Natural Antioxidant Flavonoid Mixture, Silymarin, in BALB/c Mice. Planta Med 2003;69(01):44-9. DOI |
18 | Lee JS, Kim SG, Kim HK, Lee TH, Jeong YI, Lee CM, et al. Silibinin polarizes T1/T2 immune responses through the inhibition of immunostimulatory function of dendritic cells. J Cell Physiol. 2007;210(2):385-97. DOI |
19 | Vaid M, Prasad R, Singh T, Elmets CA, Xu H, Katiyar SK. Silymarin inhibits ultraviolet radiation-induced immune suppression through DNA repair-dependent activation of dendritic cells and stimulation of effector T cells. Biochem Pharmacol. 2013;85(8):1066-76. DOI |
20 | Mady FM, Essa H, El-Ammawi T, Abdelkader H, Hussein AK. Formulation and clinical evaluation of silymarin pluronic-lecithin organogels for treatment of atopic dermatitis. Drug Des Devel Ter. 2016;10:1101. |
21 | Bakhshaee M, Jabbari F, Hoseini S, Farid R, Sadeghian MH, Rajati M, et al. Effect of silymarin in the treatment of allergic rhinitis. Otolaryngol Head Neck Surg. 2011;145(6):904-9. DOI |
22 | Luster MI, Dean JH, Germolec DR. Consensus work-shop on methods to evaluate developmental immunotoxicity. Environ health perspect. 2003;111(4):579. DOI |
23 | Riahi B, Rafatpanah H, Mahmoudi M, Memar B, Brook A, Tabasi N, et al. Immunotoxicity of paraquat after subacute exposure to mice. Food Chem Toxicol. 2010;48(6):1627-31. DOI |
24 | Devadas S, Zaritskaya L, Rhee SG, Oberley L, Williams MS. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation. J Exp Med. 2002;195(1):59-70. DOI |
25 | Neishabouri EZ, Hassan Z, Azizi E, Ostad S. Evaluation of immunotoxicity induced by diazinon in C57bl/6 mice. Toxicology. 2004;196(3):173-9. DOI |
26 | Sena LA, Li S, Jairaman A, Prakriya M, Ezponda T, Hildeman DA, et al. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity. 2013;38(2):225-36. DOI |
27 | Schieke SM, McCoy Jr JP, Finkel T. Coordination of mitochondrial bioenergetics with G1 phase cell cycle progression. Cell Cycle. 2008;7(12):1782-7. DOI |
28 | Byun HO, Kim HY, Lim JJ, Seo YH, Yoon G. Mitochondrial dysfunction by complex II inhibition delays overall cell cycle progression via reactive oxygen species production. J Cell Biochem. 2008;104(5):1747-59. DOI |
29 | Keramati MR, Balali-Mood M, Mousavi SR, Sadeghi M, Riahi-Zanjani B. Biochemical and hematological findings of Khorasan veterans 23 years after sulfur mustard exposure. J Res Med Sci. 2013;18(10):855. |
30 | Caroleo M, Rispoli V, Arbitrio M, Strongoli C, Rainaldi G, Rotiroti D, et al. Chronic administration of paraquat produces immunosuppression of T lymphocytes and astrocytosis in rats. Toxic Subst Mech. 1996;15(3):183-94. |
31 | Annunziata M, Iorio M. The levels of glutathione and hemoglobin in sheep erythrocytes as a function of age. Ital J Anim Sci. 2004;3(3):283-6. DOI |
32 | Witko-Sarsat V, Nguyen AT, Descamps-Latscha B. Immunomodulatory role of phagocyte-derived chloramines involving lymphocyte glutathione. Mediators Inflamm. 1993;2(3):235-41. DOI |
33 | Victor, V. M., Rocha, M. and De la Fuente, M. Immune cells: free radicals and antioxidants in sepsis. Int Immunopharmacol. 2004;4(3):327-47. DOI |
34 | Grifths HR. ROS as signalling molecules in T cells--evidence for abnormal redox signalling in the autoimmune disease, rheumatoid arthritis. Redox Rep. 2005;10(6):273-80. DOI |
35 | Mahmoudi M, Zamani Taghizadeh Rabe S, Bala-li-Mood M, Karimi G, Memar B, Rahnama M, et al. Immunotoxicity induced in mice by subacute exposure to berberine. J Immunotoxicol. 2016;13(2):255-62. DOI |